Mountfort Katrina, Antoniucci David, Mehran Roxana, DeLuca Giuseppe, Nef Holger, Vrolix Mathias, Khashaba Ahmed
Careggi Hospital, Firenze, Italy.
Mount Sinai Hospital, New York, US.
Interv Cardiol. 2014 Aug;9(3):180-183. doi: 10.15420/icr.2014.9.3.180.
The use of drug-eluting stents (DES) has improved clinical outcomes in percutaneous coronary intervention (PCI) procedures. However, first-generation DES were associated with safety concerns arising from the persistence of durable polymers, including late stent thrombosis. The Cre8™ DES is a novel polymer-free stent designed to overcome these issues. In a presentation at EuroPCR 2014, two clinical cases were discussed. The first was a case of high bleeding risk; the second was the case of multivessel disease with a significant risk of stent restenosis. Together, these cases illustrated the complexity of decision-making in PCI in daily practice. In both cases, the Cre8™ DES offered a safe and effective solution to these challenging cases.
药物洗脱支架（DES）的使用改善了经皮冠状动脉介入治疗（PCI）手术的临床结果。然而，第一代DES与持久聚合物的残留所引发的安全问题有关，包括晚期支架血栓形成。Cre8™ DES是一种新型无聚合物支架，旨在克服这些问题。在2014年欧洲心血管介入治疗大会（EuroPCR）的一次报告中，讨论了两个临床病例。第一个是高出血风险病例；第二个是多支血管病变且有显著支架再狭窄风险的病例。总之，这些病例说明了日常临床实践中PCI决策的复杂性。在这两个病例中，Cre8™ DES为这些具有挑战性的病例提供了安全有效的解决方案。
